TrialJournal of the American College of Cardiology2018

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.

Mikhail Kosiborod et al.PubMed ↗Publisher ↗

No numbers read from the abstract.